Last reviewed · How we verify
non-narcotic regimen with TAP block
non-narcotic regimen with TAP block is a Regional anesthesia technique / Local anesthetic injection Small molecule drug developed by University of Arizona. It is currently FDA-approved for Postoperative pain management following abdominal surgery, Component of non-narcotic analgesia regimens.
A TAP (transversus abdominis plane) block is a regional anesthesia technique that interrupts nerve signals in the abdominal wall to provide postoperative pain relief without opioids.
A TAP (transversus abdominis plane) block is a regional anesthesia technique that interrupts nerve signals in the abdominal wall to provide postoperative pain relief without opioids. Used for Postoperative pain management following abdominal surgery, Component of non-narcotic analgesia regimens.
At a glance
| Generic name | non-narcotic regimen with TAP block |
|---|---|
| Sponsor | University of Arizona |
| Drug class | Regional anesthesia technique / Local anesthetic injection |
| Modality | Small molecule |
| Therapeutic area | Anesthesia / Perioperative Pain Management |
| Phase | FDA-approved |
Mechanism of action
The TAP block involves injection of local anesthetic into the plane between the transversus abdominis and internal oblique muscles, targeting the thoracolumbar nerves that supply the abdominal wall. This regional technique provides somatic analgesia to the surgical site, reducing the need for systemic opioid medications. It is typically used as part of a multimodal pain management strategy in the perioperative period.
Approved indications
- Postoperative pain management following abdominal surgery
- Component of non-narcotic analgesia regimens
Common side effects
- Local anesthetic toxicity
- Hematoma or bleeding at injection site
- Infection
- Bowel or organ perforation
Key clinical trials
- Pain Management Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- non-narcotic regimen with TAP block CI brief — competitive landscape report
- non-narcotic regimen with TAP block updates RSS · CI watch RSS
- University of Arizona portfolio CI
Frequently asked questions about non-narcotic regimen with TAP block
What is non-narcotic regimen with TAP block?
How does non-narcotic regimen with TAP block work?
What is non-narcotic regimen with TAP block used for?
Who makes non-narcotic regimen with TAP block?
What drug class is non-narcotic regimen with TAP block in?
What development phase is non-narcotic regimen with TAP block in?
What are the side effects of non-narcotic regimen with TAP block?
Related
- Drug class: All Regional anesthesia technique / Local anesthetic injection drugs
- Manufacturer: University of Arizona — full pipeline
- Therapeutic area: All drugs in Anesthesia / Perioperative Pain Management
- Indication: Drugs for Postoperative pain management following abdominal surgery
- Indication: Drugs for Component of non-narcotic analgesia regimens
- Compare: non-narcotic regimen with TAP block vs similar drugs
- Pricing: non-narcotic regimen with TAP block cost, discount & access